Skip to main content
All lobbying filings

WILLIAMS AND JENSEN, PLLC

Lobbying for NOVOCURE INC. · Commercial stage oncology dedicated to advancement of TTF therapy to treat solid tumors.

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · New Hampshire · House · Senate · $60,000.00 income · posted Apr 20, 2026

Official filing document

 Bills named in this filing 2
  • HR 5343
    Ensuring Patient Access to Critical Breakthrough Products Act
  • S 1717
    Ensuring Patient Access to Critical Breakthrough Products Act of 2025
 Lobbying activity 2
Pharmacy

Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.

Medicare/Medicaid

Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem